Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
454
datasets available to search
ShareScore release 0.9.0
Dataset results
454 results for “Tamoxifen”
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
ClinicalTrials.gov study NCT00900744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
ClinicalTrials.gov study NCT00086749. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT00717015. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Pr
ClinicalTrials.gov study NCT05801705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arimidex Observational: Reason for and Effect of Change From Tamoxifen
ClinicalTrials.gov study NCT00246961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00210028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testosterone & Tamoxifen Trial
ClinicalTrials.gov study NCT05156606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients
ClinicalTrials.gov study NCT02062489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant
ClinicalTrials.gov study NCT00919399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer
ClinicalTrials.gov study NCT02890082. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen
ClinicalTrials.gov study NCT00532454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen in Treating Patients With Primary Liver Cancer
ClinicalTrials.gov study NCT00003424. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
ClinicalTrials.gov study NCT00667121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fl
ClinicalTrials.gov study NCT00897091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
ClinicalTrials.gov study NCT02094495. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
ClinicalTrials.gov study NCT00214110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy
ClinicalTrials.gov study NCT05669768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer.
ClinicalTrials.gov study NCT06364267. IPD Sharing: NO. Countries: 1. Publications: 0.
ESR1 and p53 Interactome Defines Mechanisms of Therapeutic Response to Tamoxifen Therapy in Luminal Breast Cancer Patients
GEO Series GSE263089. Homo sapiens. 35 samples. Type: Expression profiling by high throughput sequencing.
Tamoxifen-associated endometrial tumors expose differential enhancer activity for Estrogen Receptor alpha
GEO Series GSE94524. Homo sapiens. 135 samples. Type: Expression profiling by array; Genome binding/occupancy profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.